BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 9, 2020
View Archived Issues
Microglia protect brain via inhibition
Read More
NOX5 is a therapeutic target in diabetic kidney disease
Read More
Caladrius initiates proof-of-concept study of CLBS-119 for repair of COVID-19-induced lung damage
Read More
Hisamitsu Pharmaceutical initiates phase III study of HP-5070 in Japan
Read More
Fluvoxamine reduced the likelihood of hospitalization in patients with mild COVID-19
Read More
Topline data presented from phase III GALACTIC-HF study of omecamtiv mecarbil
Read More
TLC receives approval in Australia and Taiwan for phase I study of TLC-19
Read More
CNS leukemia cells depend on fat enzyme to survive and grow
Read More
Final data for depatuxizumab mafodotin plus temozolomide in recurrent glioblastoma
Read More
Takeda Pharmaceutical patents RIP-2 kinase inhibitors
Read More
Yumanity Therapeutics presents new SCD inhibitors
Read More
EMPOWER-Lung 1 data for cemiplimab as first-line monotherapy in NSCLC with PD-L1 >= 50%
Read More
U.S. researchers identify muscarinic M4 receptor antagonists
Read More
Sorrento discovers Salicyn-30 as new inhibitor of SARS-CoV-2 infection in vitro
Read More
Saniona AB discloses new KCNN4 blockers
Read More
Citius licenses Novellus' iPSC-derived mesenchymal stem cells for acute respiratory conditions
Read More
FDA accepts Aprea's IND for APR-548 for TP53 mutant MDS
Read More
Spartina developing SIREN technology for COVID-19
Read More
BioAtla and BeiGene amend BA-3071 agreement to grant exclusive global license
Read More
Selective PDEB inhibitor shows promising preclinical results for the treatment of cocaine addiction
Read More
Bavituximab plus pembrolizumab show promising activity in advanced gastric or GEJ cancer
Read More
First-in-human data for RO-7122290, a FAP-targeted 4-1BB agonist
Read More
Phase IIb study of lenabasum in cystic fibrosis does not meet primary endpoint
Read More
FDA clears IND for HLX-70 to treat COVID-19
Read More
Phase III study of somatrogon for growth hormone deficiency meets primary endpoint
Read More
ILC's Alfacyte shows promise in vitro against SARS-CoV-2
Read More
Vincera signs license agreement with Bayer for early development oncology portfolio
Read More
